For US Residents Only.

How Treatment May Help

PROMACTA

How Treatment May Help You How Treatment May Help You

PROMACTA is a once-daily oral medicine that helps boost your child’s platelet counts and keep them higher than before treatment.

If your child has been diagnosed with chronic ITP and other treatments have not worked well enough, the doctor may recommend PROMACTA.

The safety and benefits of taking PROMACTA for children aged 1 to 17 years with chronic ITP were evaluated across 2 clinical studies.

In 2 clinical studies, one lasting 7 weeks and the other lasting 13 weeks, when pediatric patients received PROMACTA

  • PROMACTA helped increase platelet counts to target levels*
  • PROMACTA helped maintain target platelet levels over the course of 13 weeks in the second study
  • Platelet levels started to increase within 1 to 2 weeks after starting PROMACTA and decreased within 1 to 2 weeks after stopping PROMACTA

 

In the 2 studies, 46% (6/13) and 53% (8/15) of patients, respectively, who were treated with PROMACTA and were also receiving other ITP therapy were able to reduce or discontinue their other medications for chronic ITP (mainly corticosteroids).

 

*Target levels: platelet counts equal to or greater than 50,000/mcL achieved at least once between Week 1 and Week 6 of the study.

Maintained target levels: platelet counts equal to or greater than 50,000/mcL for at least 6 of 8 weeks.